Glenmede Trust CO Na Repligen Corp Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

A detailed history of Glenmede Trust CO Na transactions in Repligen Corp stock. As of the latest transaction made, Glenmede Trust CO Na holds 6,158 shares of RGEN stock, worth $877,083. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,158

Previous 5,430 13.41%

Holding current value

$877,083

Previous $684,000 33.92%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$119.79 - $167.35 $87,207 - $121,830	728 Added 13.41%	6,158 $916,000
Q2 2024 Aug 14, 2024	BUY	$120.0 - $182.95 $124,200 - $189,353	1,035 Added 23.55%	5,430 $684,000
Q1 2024 May 15, 2024	BUY	$170.78 - $208.42 $91,708 - $111,921	537 Added 13.92%	4,395 $808,000
Q4 2023 Feb 13, 2024	BUY	$114.17 - $185.35 $7,649 - $12,418	67 Added 1.77%	3,858 $693,000
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $102,558 - $130,440	739 Added 24.21%	3,791 $602,000
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $1,079 - $1,386	7 Added 0.23%	3,052 $513,000
Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $10,719 - $14,556	66 Added 2.22%	3,045 $515,000
Q3 2022 Nov 16, 2022	SELL	$160.42 - $256.21 $702,960 - $1.12 Million	-4,382 Reduced 59.53%	2,979 $556,000
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $501,524 - $670,291	3,565 Added 93.91%	7,361 $1.19 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $149,423 - $239,128	927 Added 32.31%	3,796 $713,000
Q4 2021 Feb 15, 2022	SELL	$247.59 - $304.47 $192,377 - $236,573	-777 Reduced 21.31%	2,869 $758,000
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $140,818 - $234,403	-723 Reduced 16.55%	3,646 $1.05 Million
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $10,781 - $14,361	-65 Reduced 1.47%	4,369 $871,000
Q1 2021 May 18, 2021	BUY	$180.37 - $226.26 $19,840 - $24,888	110 Added 2.54%	4,434 $861,000
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $60,712 - $84,693	-410 Reduced 8.66%	4,324 $828,000
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $47,411 - $61,250	387 Added 8.9%	4,734 $698,000
Q2 2020 Aug 14, 2020	SELL	$94.33 - $140.48 $158,002 - $235,303	-1,675 Reduced 27.81%	4,347 $537,000
Q4 2019 Feb 12, 2020	BUY	$73.84 - $93.08 $83,365 - $105,087	1,129 Added 23.07%	6,022 $557,000
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $230,563 - $287,294	3,008 Added 159.58%	4,893 $375,000
Q2 2019 Aug 13, 2019	BUY	$54.2 - $85.95 $7,642 - $12,118	141 Added 8.08%	1,885 $162,000
Q1 2019 May 14, 2019	BUY	$49.45 - $62.8 $1,236 - $1,570	25 Added 1.45%	1,744 $103,000
Q4 2018 Feb 14, 2019	SELL	$48.26 - $68.88 $13,126 - $18,735	-272 Reduced 13.66%	1,719 $90,000
Q3 2018 Nov 15, 2018	SELL	$46.8 - $58.97 $234 - $294	-5 Reduced 0.25%	1,991 $110,000
Q2 2018 Aug 15, 2018	BUY	$35.26 - $47.04 $6,875 - $9,172	195 Added 10.83%	1,996 $94,000
Q4 2017 Feb 15, 2018	BUY	$32.53 - $38.92 $7,709 - $9,224	237 Added 15.15%	1,801 $64,000
Q3 2017 Nov 14, 2017	BUY	$36.98 - $46.06 $57,836 - $72,037	1,564	1,564 $0

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.3M

Call Options Held

350K

Put Options Held

184K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.9B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Repligen Corp Transaction History